These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24410803)

  • 1. A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients.
    Huang Y; Cheng G; Liu B; Shao P; Qin C; Li J; Hua L; Yin C
    BMC Urol; 2014 Jan; 14():8. PubMed ID: 24410803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies.
    Li X; Pan Y; Huang Y; Wang J; Zhang C; Wu J; Cheng G; Qin C; Hua L; Wang Z
    Int Urol Nephrol; 2016 Apr; 48(4):535-40. PubMed ID: 26810323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram.
    Tanaka N; Shimada K; Nakagawa Y; Hirao S; Watanabe S; Miyake M; Anai S; Hirayama A; Konishi N; Fujimoto K
    BMC Res Notes; 2015 Nov; 8():689. PubMed ID: 26581414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol.
    Nicolaiew N; Ploussard G; Chun FK; Xylinas E; Allory Y; Salomon L; de la Taille A
    Urol Int; 2013; 90(3):306-11. PubMed ID: 23295308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
    Lee A; Lim J; Gao X; Liu L; Chia SJ
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a follow-up strategy for patients with PSA ranging from 4 to 10 ng/ml via a new model to reduce unnecessary prostate biopsies.
    Zhao R; Huang Y; Cheng G; Liu J; Shao P; Qin C; Hua L; Yin C
    PLoS One; 2014; 9(9):e106933. PubMed ID: 25268808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
    Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
    BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.
    Tang P; Chen H; Uhlman M; Lin YR; Deng XR; Wang B; Yang WJ; Xie KJ
    Asian J Androl; 2013 Jan; 15(1):129-33. PubMed ID: 23291910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
    Nowroozi MR; Amini S; Kasaeian A; Zavarehei MJ; Eshraghian MR; Ayati M
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e289-97. PubMed ID: 24684767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a Correct System to Evaluate the Accuracy of Gleason Score in Prostate Cancer of Chinese Population.
    Wang J; Cheng G; Li X; Huang Y; Pan Y; Qin C; Hua L; Wang Z
    Urol Int; 2016; 96(3):295-301. PubMed ID: 26849662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of a Chinese nomogram based on muti-parametric magnetic resonance for predicting the probability of prostate cancer in patients after initial negative biopsy].
    Huang C; Ji GJ; Song G; Wang H; Chen YK; Zhou LQ
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(2):132-135. PubMed ID: 29343039
    [No Abstract]   [Full Text] [Related]  

  • 13. Chinese nomogram to predict probability of positive initial prostate biopsy: a study in Taiwan region.
    Kuo SC; Hung SH; Wang HY; Chien CC; Lu CL; Lin HJ; Guo HR; Zou JF; Lin CS; Huang CC
    Asian J Androl; 2013 Nov; 15(6):780-4. PubMed ID: 24121978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
    Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.
    Suzuki H; Komiya A; Kamiya N; Imamoto T; Kawamura K; Miura J; Suzuki N; Nakatsu H; Hata A; Ichikawa T
    Urology; 2006 Jan; 67(1):131-6. PubMed ID: 16413348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
    Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a nomogram for predicting positive repeat prostate biopsy in Chinese men].
    Li QY; Tang J; Li YM; Fei X; Zhang Y; He EH; Zhou Y
    Zhonghua Nan Ke Xue; 2012 Apr; 18(4):302-5. PubMed ID: 22574362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy.].
    Murray NP; Fuentealba C; Reyes E; Jacob O
    Arch Esp Urol; 2017 Jun; 70(5):503-512. PubMed ID: 28613202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
    Garzotto M; Hudson RG; Peters L; Hsieh YC; Barrera E; Mori M; Beer TM; Klein T
    Cancer; 2003 Oct; 98(7):1417-22. PubMed ID: 14508828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcomes of transrectal ultrasound guided biopsy of the prostate in a New Zealand population.
    Lienert AR; Davidson PJ; Wells JE
    N Z Med J; 2009 Jan; 122(1288):39-49. PubMed ID: 19182841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.